Is the Potential Threat of Shareholder Activism Heightened by the Pandemic?
LaVoie Health Science Blog
JULY 1, 2020
As biotech and pharmaceutical companies work to stabilize their clinical programs and business strategies during the significant disruptions caused by the COVID-19 pandemic, one of the potential challenges that public companies may encounter is aggressive moves by activist investors looking to leverage the economic turmoil for corporate takeovers.
52 
Let's personalize your content